1 Meadowlands Plaza
+1 201 804 3000
Cambrex is the small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle.
The company provides customers with an end-to-end partnership for the research, development and manufacture of small molecule therapeutics. With over 35 years' experience and a growing team of over 2,000 experts servicing global clients from sites in North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and dosage form development and manufacturing.
Cambrex offers a range of specialist drug substance technologies and capabilities including biocatalysis, continuous flow, controlled substances, solid state science, material characterization and highly potent APIs. In addition, Cambrex can support conventional dosage forms including oral solids, semi-solids and liquids and has the expertise to manufacture specialist dosage forms such as modified-release, fixed dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile and non-sterile ointments.
With over 35 years of active pharmaceutical ingredient development and manufacturing expertise, a growing team of more than 1,200 experts and a strong presence in the USA and Europe, we are tried and trusted across branded and generic API markets.
The drug substance business includes the development, scale-up, technology transfer and manufacturing as well as specialist technologies and capabilities such as biocatalysis, continuous flow, controlled substances, solid state science and handling highly potent APIs.
The drug product business has expertise in formulation and development of conventional dosage forms including oral solids, semi-solids and liquids, as well as specialist dosage forms such as modified-release, fixed dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile and non-sterile ointments.
Cambrex's early stage development and testing business offers early clinical phase support to customers requiring smaller quantities of drug substance and drug product supply in addition to offering standalone analytical services, including method development and validation, compendial and release testing, stability storage and testing, material characterization, impurity isolation and identification, fate and purge studies, microbiology, cleanroom services and many more.
Cambrex have also produced a number of webinars, including:
Known for our manufacturing excellence, experience and innovative science, we offer a range of career opportunities across our global network of locations.
As a team, we share one goal - to improve quality of life for our customers' patients across the world.
There’s still time to register for our webinar tomorrow on De-Risking the Solid Form Landscape of an API, 10am ET/4pm CET. Learn how predictable stability and solubility can minimize development timelines and cost: https://t.co/3ZqP2FfPJx pic.twitter.com/jLdSbUbmJz— Cambrex (@cambrex) September 18, 2019
We're ready for a great day ahead and are looking forward to showing attendees our Whippany, NJ drug product facility. pic.twitter.com/9oTH92lETM— Cambrex (@cambrex) September 16, 2019